Technology

More From Technology

Technology

Biosimilars Are No Longer Just a Big Pharma Game

“A biosimilar delayed is a biosimilar denied,” Dr. Niazi emphasizes. This philosophy captures the public-health concern behind his work. Development timelines can affect when additional treatment options become available, while program costs can influence which companies are able to participate.
Technology

AI Needs a New Monetization Layer. Velocity Is Building It

Subscriptions can remain the primary revenue engine for users who want premium capabilities, higher usage limits, or advanced features. Advertising can monetize the much larger population that prefers free access and may never become a paying customer.
Lifestyle

Why Private Healthcare Cannot Fix Staffing Without Admin

That flexibility matters on both sides of the arrangement. Stosic describes a workforce of trained secretaries who are often looking for something other than a full-time office role. Some are NHS secretaries seeking additional or freelance work. Some have worked in private hospitals and want to work remotely.
Technology

Eynat Guez Built a $3.7B Company for AI’s Hiring Boom

Speed is built in. Forward-deployed engineers map a customer's real operation and build customised agents around it during migration, with payroll live within one cycle, standard onboarding the same day, and a stated ambition of 40-plus countries and 20,000-plus workers in under eight months.